ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $223,668 | -2.8% | 4,808 | +8.4% | 0.00% | 0.0% |
| Q3 2022 | $230,000 | +11.7% | 4,434 | +2.1% | 0.00% | 0.0% |
| Q2 2022 | $206,000 | -55.0% | 4,342 | -32.5% | 0.00% | 0.0% |
| Q1 2022 | $458,000 | -19.6% | 6,433 | -15.7% | 0.00% | 0.0% |
| Q4 2021 | $570,000 | +38.3% | 7,633 | +5.3% | 0.00% | 0.0% |
| Q3 2021 | $412,000 | +2.7% | 7,249 | -20.5% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | -4.1% | 9,114 | +7.7% | 0.00% | 0.0% |
| Q1 2021 | $418,000 | +29.4% | 8,466 | +10.5% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +19.6% | 7,662 | +30.0% | 0.00% | 0.0% |
| Q3 2020 | $270,000 | -11.2% | 5,894 | -2.7% | 0.00% | -50.0% |
| Q2 2020 | $304,000 | +44.8% | 6,055 | +48.1% | 0.00% | 0.0% |
| Q1 2020 | $210,000 | -51.6% | 4,088 | -41.9% | 0.00% | 0.0% |
| Q4 2019 | $434,000 | -6.1% | 7,031 | -8.5% | 0.00% | -33.3% |
| Q3 2019 | $462,000 | -31.4% | 7,686 | -3.6% | 0.00% | -25.0% |
| Q2 2019 | $673,000 | -20.6% | 7,974 | -10.2% | 0.00% | -20.0% |
| Q1 2019 | $848,000 | +36.1% | 8,879 | +1.0% | 0.01% | +25.0% |
| Q4 2018 | $623,000 | -29.6% | 8,791 | -15.1% | 0.00% | -33.3% |
| Q3 2018 | $885,000 | -29.1% | 10,351 | -3.9% | 0.01% | -25.0% |
| Q2 2018 | $1,248,000 | +36.7% | 10,772 | -4.6% | 0.01% | +33.3% |
| Q1 2018 | $913,000 | +19.5% | 11,286 | -13.3% | 0.01% | +20.0% |
| Q4 2017 | $764,000 | +35.0% | 13,023 | +7.6% | 0.01% | 0.0% |
| Q3 2017 | $566,000 | +38.4% | 12,098 | +6.4% | 0.01% | +25.0% |
| Q2 2017 | $409,000 | +8.2% | 11,375 | -7.4% | 0.00% | 0.0% |
| Q1 2017 | $378,000 | -26.7% | 12,284 | -20.2% | 0.00% | -33.3% |
| Q4 2016 | $516,000 | +40.2% | 15,393 | +11.4% | 0.01% | +20.0% |
| Q3 2016 | $368,000 | +2.2% | 13,820 | -15.3% | 0.01% | 0.0% |
| Q2 2016 | $360,000 | -24.7% | 16,318 | +0.3% | 0.01% | -28.6% |
| Q1 2016 | $478,000 | -18.3% | 16,270 | -8.1% | 0.01% | 0.0% |
| Q4 2015 | $585,000 | +0.9% | 17,703 | +10.3% | 0.01% | -12.5% |
| Q3 2015 | $580,000 | -24.0% | 16,044 | -5.4% | 0.01% | -27.3% |
| Q2 2015 | $763,000 | +46.2% | 16,955 | -0.6% | 0.01% | +83.3% |
| Q1 2015 | $522,000 | -29.4% | 17,049 | +17.4% | 0.01% | -33.3% |
| Q4 2014 | $739,000 | +240.6% | 14,527 | +188.5% | 0.01% | +200.0% |
| Q2 2014 | $217,000 | – | 5,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |